Recent Updates
Recently added Catalysts
ELUT Positive Sentiment Score: 65/100

Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023

Monday, November 6, 2023 1 min read
Key Takeaway: Elutia Inc. has announced that it will release its third quarter 2023 financial results on November 13, 2023, after the market closes. A conference call and webcast will be held at 4:30 p.m. ET, allowing investors to participate and access the results. The company is noted for its development of biologic products that enhance compatibility between medical devices and patients, which is particularly relevant given the increasing demand for implantable technologies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Elutia is pioneering drug-eluting biomatrix products.
  • The company is focused on improving compatibility between medical devices and patients.
  • There is a growing population in need of implantable technologies, aligning with Elutia's mission.

Full Press Release Details

SILVER SPRING, Md., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that it will release its third quarter 2023 financial results after market close on Monday, November 13, 2023. Members of the Company’s management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13742087
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at https://investors.elutia.com/.
Elutia develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
matt.steinberg@finnpartners.com

Frequently Asked Questions

When will Elutia announce its Q3 2023 financial results?

Elutia will announce its Q3 2023 financial results on November 13, 2023.

What time is Elutia's conference call on November 13?

The conference call will start at 4:30 p.m. Eastern Time.

How can I access Elutia's conference call?

Call 877-407-8029 for U.S. investors or 201-689-8029 for international investors.

Where can I find Elutia's webcast after the call?

The webcast will be available in the 'Investors' section of Elutia's website.

What does Elutia focus on developing?

Elutia specializes in biologic products for enhancing medical device compatibility.

Tags: ELUT Viatris Investor Conferences Healthcare Elutia financial results biologics implantable technologies Nasdaq
Last updated: Nov 6, 2023